Scholarly Index
Maurizio Scaltriti
AstraZeneca (United States); 25,420 total citations; 283 total publications; best world rank #19
AstraZeneca (United States)
25,420Total citations
283Total publications
76H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HER2/EGFR in Cancer Research | Lifetime | 182 | US 87 | 99.17 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 703 | US 373 | 98.85 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 157 | US 96 | 98.56 |
| Lung Cancer Treatments and Mutations | Lifetime | 852 | US 393 | 98.30 |
| Clusterin in disease pathology | Lifetime | 19 | US 7 | 96.41 |
| Advanced Breast Cancer Therapies | Lifetime | 411 | US 192 | 96.70 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 111 | US 58 | 87.63 |